𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A 3′ splice site consensus sequence mutation in the intron 3 of the α-galactosidase a gene in a patient with Fabry disease

✍ Scribed by Tohru Yokoi; Kazuko Shinoda; Ichiro Ohno; Kimitaka Kato; Toshio Miyawaki; Noboru Taniguchi


Publisher
Nature Publishing Group
Year
1991
Tongue
English
Weight
573 KB
Volume
36
Category
Article
ISSN
1435-232X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Novel acceptor splice site mutation in t
✍ Takehiko Matsumura; Hitoshi Osaka; Naoya Sugiyama; Chiaki Kawanishi; Yasuko Maru 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

We found a novel acceptor splice site mutation in the invariant AG of intron 6 of a-galactosidase A (a-Gal A) gene (IVS6-1G->A) in a patient with Fabry disease by sequencing of genomic DNA. Sequencing of RT-PCR revealed the deletion of first base pair (c909del) of exon 7 in mRNA and a frameshift res

A novel mutation (E358K) in the α-galact
✍ Dr. Takashi Miyazaki; Mitsuharu Kajita; Sachiko Ohmori; Naoki Mizutani; Toshimit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

The enzyme deficiency causes the intralysosomal accumulation of glycosphingolipids. The affected hemizygotes manifest acroparethesis, angiokeratoma, hypohidrosis, corneal opacities, and progressive vascular diseases of the kidney, heart, and brain. The human a-Gal A cDNA (Bishop et al., 1986) and ge

A sensitive mutation screening strategy
✍ Lianne C. Blanch; Cathy Meaney; C. Phillip Morris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

Fabry disease is an X-linked recessive lysosomal storage disorder caused by a deficiency of a-galactosidase A (a-gal; EC 3.2.1.22). In the past, it has been difficult to give an unequivocal diagnosis of carrier status in Fabry disease because of the overlap between normal and heterozygote enzyme lev